Member Info for 86KB

@Goldgirl hope you have a smile on your face today. I know there has been alot of naysayers on this board when sp was down. Sometimes just have to walk away it from it all.

Gone into auction into close. Just needed to close above 3.18 and done well above that today, bodes well for tomorrow.

If I remember correctly, I think they would get an upfront payment and royalties too.

When it went to 7s last time it was a hypothesis but the recent rns had proven data and still didn't do much due to placing. But think lanstead maybe done with selling and placing churn done too so may see it get to where it should even without news.

Current Mcap just under £15m, ceo mentioned we should already be at billion in comparison to other companies who are at similar stages. Add on the deals and the numbers are crazy from these levels.

They have already proved their hypothesis that it works. Its just a case of sharing detailed findings which they were holding off until patents.

P140 is non-immunosuppressive: Unlike the most advanced therapies currently available for the treatment of autoimmune diseases, these findings indicate that P140 does not reduce or block the body's ability to mount a specific immune response.

· P140 is effective and safe: These findings confirm P140's potential as a safe and effective treatment for patients suffering from systemic lupus erythematosus (SLE).

Gut feeling says we have news coming, look at the price, back up we go after profit taking.

Lets see if we get news tomorrow and then there will be a scramble to get back in if they let you.

Out of Auction now

Tiger its in auction so wouldn't be able to buy or sell

Going back into Auction again?

Relevant therapy markets in this area are forecast to reach global sales of c.$360 billion by 2030. There have been 11 relevant therapy product licensing deals averaging $1bn total deal value in last 2 years. (UBS Investment Banking Reports).

Bobat lol did you miss your entry? Bope nobody falls for it. It is still cheap considering they are looking at billion deals.

I don't think we need a 1 code, this dropped due to placing churn and to be the only company with a p140 platform that diagnoses all autoimmune diseases it was already undervalued. Not to mention they have been in advanced discussions for awhile. He did say it was going to be a transformational year and the price action suggests either overhang cleared or news on the way.

@goldgirl where are you at?

Went to 7.3 last time we should get double digits and beyond

Certainly looks that way

Out of auction and gone higher.

If deals have been signed then this will certainly gap up big time since they were looking at over a billion deal.

Gone into Auction